HEMANGIOSARCOMA
Ruthanne Chun, DVM, Feline and Canine Hemangiosarcoma, Compend Contin Educ Pract Vet;(1999);21;7:622
ABSTRACT: Hemangiosarcoma (HSA) is a common malignancy in dogs but is rare in cats. Splenic HSA in cats is a highly metastatic disease with a poor long-term prognosis; hypodermal HSA in cats has a fair long-term prognosis and may be cured with surgery alone. Most forms of the disease in dogs are associated with a poor prognosis, although the dermal form can potentially be cured with surgery alone. Staging of the tumor is essential for accurate treatment and prognosis in both species. Microscopic metastatic disease at the time of diagnosis is likely in dogs with hypodermal HSA and in dogs and cats with visceral HSA. Recommended adjuvant therapy in animals with microscopic metastatic disease is a doxorubicinbased chemotherapy protocol.
Our veterinary oncologist provides these information sheets for patients:
CHEMOTHERAPY FOR DOGS AND CATS
CHEMOTHERAPY: COMMONLY USED DRUGS, ADMINISTRATION, AND SIDE EFFECTS